166 related articles for article (PubMed ID: 32175921)
21. Tumor-associated macrophages (TAMs) depend on ZEB1 for their cancer-promoting roles.
Cortés M; Sanchez-Moral L; de Barrios O; Fernández-Aceñero MJ; Martínez-Campanario MC; Esteve-Codina A; Darling DS; Győrffy B; Lawrence T; Dean DC; Postigo A
EMBO J; 2017 Nov; 36(22):3336-3355. PubMed ID: 29038174
[TBL] [Abstract][Full Text] [Related]
22. A narrative review of tumor-associated macrophages in lung cancer: regulation of macrophage polarization and therapeutic implications.
Sedighzadeh SS; Khoshbin AP; Razi S; Keshavarz-Fathi M; Rezaei N
Transl Lung Cancer Res; 2021 Apr; 10(4):1889-1916. PubMed ID: 34012800
[TBL] [Abstract][Full Text] [Related]
23. Predicting the herbal medicine triggering innate anti-tumor immunity from a system pharmacology perspective.
Xiao Y; Zhang L; Zhu J; Zhang Y; Yang R; Yan J; Huang R; Zheng C; Xiao W; Huang C; Wang Y
Biomed Pharmacother; 2021 Nov; 143():112105. PubMed ID: 34560533
[TBL] [Abstract][Full Text] [Related]
24. The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization.
Zheng X; Sarode P; Weigert A; Turkowski K; Chelladurai P; Günther S; Kuenne C; Winter H; Stenzinger A; Reu S; Grimminger F; Stiewe T; Seeger W; Pullamsetti SS; Savai R
Cancer Res; 2023 Jul; 83(14):2345-2357. PubMed ID: 37205635
[TBL] [Abstract][Full Text] [Related]
25. TREM-1low is a novel characteristic for tumor-associated macrophages in lung cancer.
Zhang G; Liu H; Huang J; Chen S; Pan X; Huang H; Wang L
Oncotarget; 2016 Jun; 7(26):40508-40517. PubMed ID: 27244892
[TBL] [Abstract][Full Text] [Related]
26. Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression.
Wang R; Zhang J; Chen S; Lu M; Luo X; Yao S; Liu S; Qin Y; Chen H
Lung Cancer; 2011 Nov; 74(2):188-96. PubMed ID: 21601305
[TBL] [Abstract][Full Text] [Related]
27. The intratumoral distribution influences the prognostic impact of CD68- and CD204-positive macrophages in non-small cell lung cancer.
Li Z; Maeda D; Yoshida M; Umakoshi M; Nanjo H; Shiraishi K; Saito M; Kohno T; Konno H; Saito H; Minamiya Y; Goto A
Lung Cancer; 2018 Sep; 123():127-135. PubMed ID: 30089583
[TBL] [Abstract][Full Text] [Related]
28. Hedgehog signaling promotes tumor-associated macrophage polarization to suppress intratumoral CD8+ T cell recruitment.
Petty AJ; Li A; Wang X; Dai R; Heyman B; Hsu D; Huang X; Yang Y
J Clin Invest; 2019 Dec; 129(12):5151-5162. PubMed ID: 31638600
[TBL] [Abstract][Full Text] [Related]
29. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
Bonde AK; Tischler V; Kumar S; Soltermann A; Schwendener RA
BMC Cancer; 2012 Jan; 12():35. PubMed ID: 22273460
[TBL] [Abstract][Full Text] [Related]
30. TFEB is a master regulator of tumor-associated macrophages in breast cancer.
Li Y; Hodge J; Liu Q; Wang J; Wang Y; Evans TD; Altomare D; Yao Y; Murphy EA; Razani B; Fan D
J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32487570
[TBL] [Abstract][Full Text] [Related]
31. Human tumor-associated monocytes/macrophages and their regulation of T cell responses in early-stage lung cancer.
Singhal S; Stadanlick J; Annunziata MJ; Rao AS; Bhojnagarwala PS; O'Brien S; Moon EK; Cantu E; Danet-Desnoyers G; Ra HJ; Litzky L; Akimova T; Beier UH; Hancock WW; Albelda SM; Eruslanov EB
Sci Transl Med; 2019 Feb; 11(479):. PubMed ID: 30760579
[TBL] [Abstract][Full Text] [Related]
32. Expression of scavenger receptor MARCO defines a targetable tumor-associated macrophage subset in non-small cell lung cancer.
La Fleur L; Boura VF; Alexeyenko A; Berglund A; Pontén V; Mattsson JSM; Djureinovic D; Persson J; Brunnström H; Isaksson J; Brandén E; Koyi H; Micke P; Karlsson MCI; Botling J
Int J Cancer; 2018 Oct; 143(7):1741-1752. PubMed ID: 29667169
[TBL] [Abstract][Full Text] [Related]
33. TGR5 deficiency activates antitumor immunity in non-small cell lung cancer
Zhao L; Zhang H; Liu X; Xue S; Chen D; Zou J; Jiang H
Acta Pharm Sin B; 2022 Feb; 12(2):787-800. PubMed ID: 35256947
[TBL] [Abstract][Full Text] [Related]
34. BRD4 Inhibition by AZD5153 Promotes Antitumor Immunity via Depolarizing M2 Macrophages.
Li X; Fu Y; Yang B; Guo E; Wu Y; Huang J; Zhang X; Xiao R; Li K; Wang B; Hu J; Sun C; Chen G
Front Immunol; 2020; 11():89. PubMed ID: 32184777
[TBL] [Abstract][Full Text] [Related]
35. Macrophages are metabolically heterogeneous within the tumor microenvironment.
Geeraerts X; Fernández-Garcia J; Hartmann FJ; de Goede KE; Martens L; Elkrim Y; Debraekeleer A; Stijlemans B; Vandekeere A; Rinaldi G; De Rycke R; Planque M; Broekaert D; Meinster E; Clappaert E; Bardet P; Murgaski A; Gysemans C; Nana FA; Saeys Y; Bendall SC; Laoui D; Van den Bossche J; Fendt SM; Van Ginderachter JA
Cell Rep; 2021 Dec; 37(13):110171. PubMed ID: 34965415
[TBL] [Abstract][Full Text] [Related]
36. Transcription factor Zhx2 is a checkpoint that programs macrophage polarization and antitumor response.
Tan S; Wang Z; Li N; Guo X; Zhang Y; Ma H; Peng X; Zhao Y; Li C; Gao L; Li T; Liang X; Ma C
Cell Death Differ; 2023 Sep; 30(9):2104-2119. PubMed ID: 37582865
[TBL] [Abstract][Full Text] [Related]
37. Tumor cell-released autophagosomes (TRAPs) promote immunosuppression through induction of M2-like macrophages with increased expression of PD-L1.
Wen ZF; Liu H; Gao R; Zhou M; Ma J; Zhang Y; Zhao J; Chen Y; Zhang T; Huang F; Pan N; Zhang J; Fox BA; Hu HM; Wang LX
J Immunother Cancer; 2018 Dec; 6(1):151. PubMed ID: 30563569
[TBL] [Abstract][Full Text] [Related]
38. Natural compounds: A new perspective on targeting polarization and infiltration of tumor-associated macrophages in lung cancer.
Zhou X; Wang X; Sun Q; Zhang W; Liu C; Ma W; Sun C
Biomed Pharmacother; 2022 Jul; 151():113096. PubMed ID: 35567987
[TBL] [Abstract][Full Text] [Related]
39. IL-10 derived from M2 macrophage promotes cancer stemness via JAK1/STAT1/NF-κB/Notch1 pathway in non-small cell lung cancer.
Yang L; Dong Y; Li Y; Wang D; Liu S; Wang D; Gao Q; Ji S; Chen X; Lei Q; Jiang W; Wang L; Zhang B; Yu JJ; Zhang Y
Int J Cancer; 2019 Aug; 145(4):1099-1110. PubMed ID: 30671927
[TBL] [Abstract][Full Text] [Related]
40. CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Fujiwara T; Yakoub MA; Chandler A; Christ AB; Yang G; Ouerfelli O; Rajasekhar VK; Yoshida A; Kondo H; Hata T; Tazawa H; Dogan Y; Moore MAS; Fujiwara T; Ozaki T; Purdue E; Healey JH
Mol Cancer Ther; 2021 Aug; 20(8):1388-1399. PubMed ID: 34088832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
